Innate Pharma S.A.

NASDAQ: IPHA · Real-Time Price · USD
2.11
-0.07 (-3.21%)
At close: Aug 15, 2025, 3:59 PM
2.12
0.47%
After-hours: Aug 15, 2025, 04:00 PM EDT

Innate Pharma S.A. Cash Flow Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Net Income
-49.47M -34.05M -7.57M -62.63M -57.97M -15.38M -45.48M -77.37M
Depreciation & Amortization
1.99M 2.59M 5.09M 6.03M 4.42M 4.42M 4.57M 8.76M
Stock-Based Compensation
3.94M 4.56M 3.56M 1.53M 2.12M 2.18M 1.31M 1.25M
Other Working Capital
39.16M -3.91M -13.99M -23.46M -636K 6.55M -12.33M 10.68M
Other Non-Cash Items
-2.52M -9.42M 13.85M 53.64M 67.61M 16.68M -919K 71.41M
Deferred Income Tax
n/a -27.92M -43.83M -10.17M -22.84M -28.58M n/a n/a
Change in Working Capital
39.16M 18.26M -31.58M -20.06M -12.5M -8.22M -9.88M -4.25M
Operating Cash Flow
-6.9M -18.06M -32.56M -31.67M -19.15M -26.12M -58.4M -24.94M
Capital Expenditures
-391K -325K -354K -1.01M -1.12M -1.42M -1.33M -1.77M
Cash Acquisitions
n/a 300K 300K n/a n/a 5K 7K -25K
Purchase of Investments
n/a -2 -2 n/a n/a n/a n/a n/a
Sales Maturities Of Investments
9.59M 45.54M 45.54M 3M 3M n/a n/a n/a
Other Investing Acitivies
1K 22.13M 20.98M 1.26M 1.21M 52.5K 36.5K -453K
Investing Cash Flow
9.2M 21.81M 20.63M 2.05M 1.88M -1.37M -1.28M -1.8M
Debt Repayment
-8.94M n/a n/a -1.07M -1.07M n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
2.93M -6.05M -2.78M -1.24M -952K 27.24M 27.07M -937K
Financial Cash Flow
-6.01M -5.05M -1.97M -2.31M -1.83M 27.43M 27.13M -876K
Net Cash Flow
66.4M 69.18M -13.62M -31.54M -19.53M -1.03M -33.04M -27.56M
Free Cash Flow
-7.29M -18.38M -32.91M -32.68M -20.28M -27.53M -59.73M -26.72M